by Acellular dermal matrices are reconstituted human tissues used in reconstructive procedures like breast reconstruction and hernia repair. They provide strength, flexibility and are readily absorbed by the body during healing, reducing complications. ADMs are used as scaffolding to support new tissue regrowth and minimize scarring.
The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The surging demand for a wide range of biologics and medical devices is expected to drive the U.S. acellular dermal matrices market over the forecast period. Acellular dermal matrices find extensive usage as reinforcement patches and scaffolds for soft tissue repairs and reconstructions in medical applications like breast reconstruction surgeries and hernia repairs. The increasing volume of such reconstructive surgeries performed annually in the U.S. is anticipated to propel the demand for acellular dermal matrices.
SWOT Analysis
Strength: The U.S. Acellular Dermal Matrices Market is witnessing strong growth in demand for soft tissue reconstruction procedures.
Weakness: High costs associated with surgeries and medical procedures pose affordability issues for some patients.
Opportunity: Rising geriatric population and increasing incidence of soft tissue injuries create scope for further market expansion.
Threats: Stringent regulations and limitations on reimbursement policies act as barriers to market growth.
Key Takeaways
The Global U.S. Acellular Dermal Matrices Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.
The Western region currently dominates the market and is expected to maintain its leading position during the forecast period. Key factors propelling growth in the region include higher medical spending, growing obesity rates, and large patient pool.
Key players
Key players operating in the U.S. Acellular Dermal Matrices Market are Biomet, Inc., Wright Medical Technology, Inc., Smith & Nephew Plc, and Stryker. Biomet, Inc. accounts for a major market share owing to its diverse product portfolio and wide geographic presence across the country.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
